Recognising Excellence in Longevity

Clinic Accreditation
Our comprehensive clinic accreditation assesses your entire practice environment — from your clinical governance and patient engagement processes to infrastructure and staff expertise. Clinics that achieve BILM accreditation demonstrate their commitment to delivering longevity medicine grounded in robust evidence and best clinical practices. This accreditation is a mark of trust and excellence for patients and partners alike.

Protocol Accreditation
BILM accredits clinical protocols specifically designed for longevity interventions to ensure they align with GCP standards, ethical guidelines, and the latest scientific research. Accredited protocols have undergone rigorous review by our expert panel, ensuring they are optimally designed for efficacy, safety, and regulatory compliance. This service benefits clinics, sponsors, and researchers seeking validation and credibility for their study designs.

Fellowship and Post-Nominal Recognition (FBILM)
To recognise individual excellence and leadership in longevity medicine, BILM confers Fellowships to practitioners and researchers who demonstrate exceptional experience and contribution to the field. Fellows are granted the distinguished post-nominal letters FBILM, symbolising their commitment to advancing the science and clinical application of longevity medicine. Use the Contact Us form for the application form.

Accreditation Criteria
BILM’s accreditation standards are designed to ensure excellence, safety, and scientific rigour in longevity medicine practice and research. Clinics and protocols are assessed against key criteria including:
01. Clinical Governance
Clear policies and leadership ensuring quality control, patient safety, ethical practice, and data protection.
02. Staff Qualifications and Training
Demonstrated expertise of clinicians and staff, including ongoing education in longevity medicine.
03. Patient-Centred Care
Transparent informed consent, personalised treatment aligned with evidence, and robust monitoring of outcomes and adverse events.
04. Protocol Integrity
Adherence to scientifically validated protocols, reproducibility, and compliance with regulatory requirements.
05. Facility and Equipment Standards
Adequate infrastructure, technology, and safety measures suitable for clinical interventions in longevity medicine.
06. Continuous Improvement
Mechanisms for audit, feedback, staff development, and protocol updates reflecting new research.
Accreditation Process
BILM’s accreditation follows a stepwise, collaborative, and transparent process designed to support clinics and researchers through successful certification:
01. Preliminary Enquiry and Eligibility Check
Initial review of your organisation and protocols to confirm fit for accreditation.
02. Application Submission
Comprehensive submission of documentation, including clinical policies, staff CVs, protocol details, and operational procedures.
03. Document Review
Rigorous assessment by BILM’s expert panel to verify conformity with accreditation criteria.
04. Site Assessment (Optional)
In-person or virtual audits may be conducted for in-depth evaluation.
05. Feedback and Remediation
Detailed report provided, with areas for improvement identified and support offered to address any gaps.
06. Final Approval and Certification
Successful applicants receive official BILM accreditation certificates and the right to use the BILM accreditation marque.
07. Ongoing monitoring
Annual reviews and re-accreditation processes ensure continued compliance and excellence.

Latest Case Studies
Some of our recent clients who have benefitted from our partnership
Clino Longevity Clinic
Clino wanted to ensure that every aspect of their longevity protocol and service met rigorous evidence-based practice to actually help improve the healthspan of their patients. they were one of the first clinics in the UK to attain full accreditation.
A National Pharmaceutical (NDA)
Wanted a translation of their IP into a GCP compliant protocol ready for clinical trials and assistance with their submission with the MHRA. BILM were able to supply PIs
A supplement Company (NDA)
Wanted help in creating a evidence-based multi-ingredient nootropic with proven benefits for their customers. With our help they were able to bring something to market with appropriate reports to back up efficacy.
